Bliss GVS Pharma Limited
Bliss GVS Pharma Limited (BLISSGVS.BO) Stock Technical Analysis & Trading Signals
Live technical indicators, trading signals, and momentum insights for Bliss GVS Pharma Limited (BSE:BLISSGVS.BO).
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerBLISSGVS.BO Technical Analysis Summary
Bliss GVS Pharma Limited stock currently shows a bullish trend, supported by momentum and strong buying pressure.
Overall, Bliss GVS Pharma Limited remains neutral, with indicators showing mixed momentum.
RSI (14): 71.17
Stochastic %K: 90.17
Williams %R: -5.61
Rate of Change (ROC): 20.95
Takeaway:Bliss GVS Pharma Limited shows overheated momentum, with risk of near-term pullback.
MACD: 12.79
ADX: 26.03
ATR (14): 13.09
CCI (14): 112.75
Takeaway:Bliss GVS Pharma Limited shows a firm trend supported by momentum, though one signal suggests caution.
Takeaway:Bliss GVS Pharma Limited trades closer to resistance, supported by stronger momentum within bands.
Takeaway:Bliss GVS Pharma Limited trades near the upper channel, signaling resistance and risk of pullback.
Overall Takeaway:BLISSGVS.BO shows bullish money flow, with volume and vigor supporting buyers.
Bullish Signals
RSI above 50 → positive momentum from buyers.
MACD above 0 → bullish trend confirmation.
ADX above 20 → strong underlying trend.
Price trading above middle Bollinger Band → mid-term support intact.
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
Price near upper Bollinger Band → potential resistance and pullback risk.
Overall Recommendation:Bliss GVS Pharma Limited currently shows a Buy with caution signal — momentum and trend strength are positive, but price is close to resistance and may face short-term pullbacks.